Handok Pharm enjoys brisk sales in three quarters

Handok Pharm said it reaped 161.3 billion won for nine months of this year thanks to brisk sales of Amaryl (41.6 billion won vs. 30.5 billion won from a year earlier) and Tritace (18.0 billion won vs. 13.0 billion won from a year earlier). The net profit recorded 13.7 billion won.

The company's operating income in the cited period posted 23.5 billion won with ordinary income of 21.3 billion ...